David Alexoff
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$1.9MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 9, 2020 | NIH | SBIR Phase II Commercialization of a proprietary Ga-68 PSMA-targeted drug for PET imaging in recurrent prostate cancer | $248K | FIVE ELEVEN PHARMA, INC. |
| Apr 16, 2019 | NIH | SBIR Phase II Commercialization of a proprietary Ga-68 PSMA-targeted drug for PET imaging in recurrent prostate cancer | $853K | FIVE ELEVEN PHARMA, INC. |
| Aug 10, 2018 | NIH | SBIR Phase II Commercialization of a proprietary Ga-68 PSMA-targeted drug for PET imaging in recurrent prostate cancer | $299K | FIVE ELEVEN PHARMA, INC. |
| Jul 31, 2017 | NIH | SBIR Phase I Development of novel gallium-68 bisphosphonate for imaging bone metastases in prostate cancer | $225K | FIVE ELEVEN PHARMA, INC. |
| Mar 1, 2017 | NIH | SBIR Phase I A low-cost automated Gallium-68 drug preparation device for diagnostic PET imaging | $225K | FIVE ELEVEN PHARMA, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,146
Awards as PI#417
Patents#273
Companies
- FIVE ELEVEN PHARMA, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.